Latest Industry Insights
Industry Insight
Cinderella and Mass Spectrometry: Insightful Multi-Dimensional Data Analysis
Proteomics is a powerful technology for analyzing low-abundance proteins for disease research. But it’s stalled by imprecise and often irreproducible data analysis. Here, David Chiang, Founder of Sage-N Research, explains how his company uses multidimensional separation to improve peptide identification in MS/MS.
Industry Insight
Data-Independent Acquisition: A Superior Technique in Mass Spectrometry?
Whilst Mass Spectrometry is undoubted in its status as a central part of the proteomics toolkit, there is still debate about the way that MS data should be acquired and analyzed. Here, we talk to Florian Marty, Director Global Product Support at Biognosys AG, about why he believes that data-independent acquisition is a superior acquisition technique.
Industry Insight
Next Generation Sequencing for the Masses?
Thermo Fisher Scientific’s Oncomine Dx Target Test, a cancer diagnostics panel, is set to be made available to 160 million people in the US through both Medicare and Medicaid and private insurers. We spoke with Joydeep Goswami, president of Clinical NGS and Oncology for Thermo Fisher Scientific, about the progress of NGS tests in the clinic.
Industry Insight
User-friendly, Simple GC's Make Waves in the Cannabis Industry
We catch up with Andrew James from Ellutia to discuss how and why their 200 Series GC is proving popular for testing potency, flavour profiling, and residual solvents.
Industry Insight
Three Ways a CDS Can Improve Data Integrity and Compliance
Today’s chromatography lab needs to meet stringent regulations around data integrity; all analyses must be conducted with total transparency, and workflows must be robust and secure. Chromatography data systems (CDS) are incredibly effective at improving overall efficiencies and reducing user-error in the lab, but they can also advance compliance and data integrity.
Industry Insight
Revolutionizing the World of Pipetting
Necessity is the mother of invention, and nowhere is this more clearly demonstrated than in the laboratory. We caught up with Alex Studer, VP of Marketing and Innovation at INTEGRA Biosciences, to discuss the company’s aim to transform the world of pipetting.
Industry Insight
Advances in Analytical Technology: Deciphering Complex Matrices
With justice and health in the balance, modern forensic toxicology drug testing labs are expected to detect and quantify a wide range of drugs and metabolites, from Fentanyl to novel psychoactive substances (NPS), at very low levels in biological matrices. The drug concentrations also need to be correlated with the impairment of the individual with absolute certainty, but labs face increasing pressures due to growing caseloads, sample backlogs, and budget restrictions.
Industry Insight
Building in Purity
Laboratories rely on the constant provision of high quality water for a variety of purposes, from glass washing to reagent preparation and instrumental analysis. It is all too easy to take this valuable commodity for granted yet, behind the scenes, a great deal of thought goes into designing a facility that reliably and cost-effectively provides water of the required quality on a round the clock basis.
Industry Insight
How to Address Data Integrity Challenges
Data integrity continues to be a hot topic for regulatory agencies in the pharmaceutical industry. Companies are making tremendous efforts to ensure their data integrity capabilities are robust. We spoke to two experts, to learn more about how Chromeleon can help demonstrate regulatory compliance and help overcome CDS data integrity challenges.
Industry Insight
Carrying the Torch for Scientific Glassblowing
Despite the important role glass plays in science, the skill to develop the glassware is in decline. Scientific glassblowing has now been classed as an endangered craft by The Radcliffe Trust.
Advertisement